Ascentage Pharma has obtained approval for its new BCR-ABL1 TKI, olverembatinib, in Macau for haematological malignancy ...

GSK and MMV have announced the launch of tafenoquine to prevent the relapse of P. vivax malaria in Brazil and Thailand.

The UK life science industry is crossing its fingers as a Labour government takes the reigns following 14 years of ...

Fucaso, a BCMA CAR T-cell therapy, is co-developed by Innovent and IASO Bio and was approved to treat multiple myeloma in ...

Approval is based on positive data from the Phase III FLAURA2 trial where Tagrisso plus chemotherapy showed PFS of 24.4 ...

As Finland administers the world’s first avian influenza vaccine for humans, the WHO says H5N1 has “pandemic potential”.

Whilst Regeneron and Sanofi secured approval in Europe for COPD, the FDA has delayed Dupixent’s application review for the ...

As the UK transitions into a Labour party government, the pharma industry urges for boosted investment and talent attraction.

Roche has received approval from the US FDA for the Vabysmo prefilled syringe (PFS) for treating three leading causes of ...

Boehringer Ingelheim and OSE Immunotherapeutics have announced the progression of a SIRPα inhibitor antibody, BI 770371, to ...

Semnur Pharmaceuticals has signed a letter of intent to go public via a merger with the special purpose acquisition company ...

Curevac has announced a restructuring plan aimed at sharpening its focus on high-value messenger RNA (mRNA) projects, ...